Concurrent abnormal expression of erbB-2, myc and ras genes is associated with poor outcome of ovarian cancer patients. (Q41681790)
Jump to navigation
Jump to search
scientific article published on July 1995
Language | Label | Description | Also known as |
---|---|---|---|
English | Concurrent abnormal expression of erbB-2, myc and ras genes is associated with poor outcome of ovarian cancer patients. |
scientific article published on July 1995 |
Statements
Concurrent abnormal expression of erbB-2, myc and ras genes is associated with poor outcome of ovarian cancer patients (English)
Katsaros D
Zola P
Louason G
Sanfilippo B
Isaia E
Arisio R
Giardina G